Has Lauren Ing, MD received payments from drug or device companies?

Yes. Drug and device makers reported $741 in general payments to Lauren Ing, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lauren Ing, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lauren Ing, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lauren Ing, MD

Obstetrics & Gynecology · Honolulu, HINPI 1235794454

Payments from drug & device makers

$741in general payments, 2019–2025

Across 20 payments — averaging $37.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Hologic Sales And Service, LLC$262
Amgen$195
Gen-probe Sales & Service, Inc.$102
Astellas Pharma US Inc$51
Bayer$42
Exeltis, USA Inc.$38
plus $50 from 2 others

What the payments were for

Food & beverage$741100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Hologic Sales And Service, LLC	2	$262
Amgen	8	$195
Gen-probe Sales & Service, Inc.	1	$102
Astellas Pharma US Inc	2	$51
Bayer	2	$42
Exeltis, USA Inc.	2	$38
Convatec Inc.	2	$38
Merck	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MYOSURE TISSUE REMOVAL DEVICE$137
ACESSA PROVU SYSTEM$137
FLUENT FLUID MANAGEMENT SYSTEM$137
Cervical Cancer Screening$125
Sexually Transmitted Infectious Disease$125
Aptima$102

How this compares

$741 in reported general payments places this provider in the 65th percentile of 225 obstetrics & gynecology providers in Hawaii.

See all obstetrics & gynecology providers in Hawaii →

Medicare billing

Part B allowed, 2024

$1,937

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Honolulu

Bliss KaneshiroHonolulu$62K
Katherine HuangHonolulu$57K
Richard McCartinHonolulu$32K
Tricia WrightHonolulu$22K
Bradley SakaguchiHonolulu$11K
Harry YoshinoHonolulu$7K
Lynette TsaiHonolulu$6K
Franklin DaoHonolulu$5K
Kurt YoshinoHonolulu$4K
Jennifer WongHonolulu$4K

See the full list for Hawaii →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →